{"id":"W3214164674","doi":"10.1182/blood-2021-151208","title":"PIK-001 a Novel Small Molecule Inhibitor of Pikfyve for Treatment of Multiple Myeloma (MM)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Ex vivo; In vivo; Pharmacology; Viability assay; Multiple myeloma; Cell culture; Biology; Immunology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000543323,0.0000939571,0.0002251785,0.00001227084,0.00001963659,0.000004630919,0.00005446525,0.0001000257,0.0002020885],"category_scores_gemma":[0.0002962356,0.00007019093,0.0001386861,0.000049969,0.00002545423,0.000009618462,0.00002052648,0.00001384964,0.000002297331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001592965,"about_ca_system_score_gemma":0.00004648883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002278774,"about_ca_topic_score_gemma":0.00002329579,"domain_scores_codex":[0.9993566,0.00001069023,0.0002393785,0.0001858805,0.00009219704,0.0001152619],"domain_scores_gemma":[0.999315,0.0002152498,0.000119777,0.0001792084,0.0001386727,0.0000321246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004837292,0.003349677,0.002285147,0.00007609121,0.00009097441,0.000001748969,0.00005178834,0.000001742092,0.9884866,0.00003711896,0.00001400476,0.005556712],"study_design_scores_gemma":[0.003775681,0.0002197034,0.001395888,0.00003634019,0.0001286932,0.000003436097,0.00008736703,0.000209325,0.99323,0.00003724355,0.000797162,0.00007913489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976892,0.0003629806,0.00009858468,0.00005084461,0.00002159291,0.00009991215,0.0001784463,0.00001345811,0.001484952],"genre_scores_gemma":[0.9958196,0.00002531926,0.003450597,0.00001301616,0.0001018542,0.00006272128,0.000108043,0.000008298181,0.0004104965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005477577,"threshold_uncertainty_score":0.2862303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05673721515622571,"score_gpt":0.2632742377658461,"score_spread":0.2065370226096204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}